CA2017636A1 - Derivative of tissue-type plasminogen activator - Google Patents
Derivative of tissue-type plasminogen activatorInfo
- Publication number
- CA2017636A1 CA2017636A1 CA2017636A CA2017636A CA2017636A1 CA 2017636 A1 CA2017636 A1 CA 2017636A1 CA 2017636 A CA2017636 A CA 2017636A CA 2017636 A CA2017636 A CA 2017636A CA 2017636 A1 CA2017636 A1 CA 2017636A1
- Authority
- CA
- Canada
- Prior art keywords
- derivative
- plasminogen activator
- tissue
- type plasminogen
- glycosylated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Luminescent Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The tissue plasminogen activator (t-PA) derivative is not glycosylated and has the following amino-acid sequence: <IMAGE>
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3917781 | 1989-05-31 | ||
DEP3917781.5 | 1989-05-31 | ||
DEP3923339.1 | 1989-07-14 | ||
DE3923339A DE3923339A1 (en) | 1989-05-31 | 1989-07-14 | FABRIC PLASMINOGEN ACTIVATOR DERIVATIVE |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2017636A1 true CA2017636A1 (en) | 1990-11-30 |
CA2017636C CA2017636C (en) | 2000-05-02 |
Family
ID=25881452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002017636A Expired - Fee Related CA2017636C (en) | 1989-05-31 | 1990-05-28 | Derivative of tissue-type plasminogen activator |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0400545B1 (en) |
JP (1) | JPH0327286A (en) |
AT (1) | ATE119940T1 (en) |
AU (1) | AU623781B2 (en) |
CA (1) | CA2017636C (en) |
CZ (1) | CZ282035B6 (en) |
DD (1) | DD300109A5 (en) |
DE (2) | DE3923339A1 (en) |
ES (1) | ES2070210T3 (en) |
FI (1) | FI101475B (en) |
HU (1) | HU216870B (en) |
IE (1) | IE66006B1 (en) |
IL (1) | IL94539A (en) |
NO (1) | NO902405L (en) |
NZ (1) | NZ233796A (en) |
PT (1) | PT94227B (en) |
ZA (1) | ZA904089B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3942144A1 (en) * | 1989-12-20 | 1991-06-27 | Boehringer Mannheim Gmbh | STABILIZATION OF K1K2P PRO |
AU2660397A (en) * | 1996-04-05 | 1997-10-29 | Board Of Regents, The University Of Texas System | Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA833174B (en) * | 1982-05-05 | 1984-08-29 | Genentech Inc | Human tissue plasminogen activator |
FR2594845B1 (en) * | 1986-02-21 | 1989-12-01 | Genetica | MICROBIOLOGICAL PREPARATION OF THE HUMAN PLASMINOGEN TISSUE ACTIVATOR (T-PA) AND CONVERSION OF THE ENZYME SO OBTAINED IN ITS ACTIVE FORM |
DE3643158A1 (en) * | 1986-04-21 | 1987-11-19 | Boehringer Mannheim Gmbh | TISSUE PLASMINOGEN ACTIVATOR (TPA) DERIVATIVE AND ITS PRODUCTION |
FI100106B (en) * | 1986-12-05 | 1997-09-30 | Novartis Ag | A process for the preparation of a plasminogen single-stranded recombinant activator |
IL87276A (en) * | 1987-08-03 | 1995-07-31 | Fujisawa Pharmaceutical Co | Analog of tissue plasminogen activator comprising only the kringle 2 and protease domain dna encoding the same processes for the preparation thereof and pharmaceutical compositions containing the same |
US5094953A (en) * | 1988-03-21 | 1992-03-10 | Genentech, Inc. | Human tissue plasminogen activator variants |
DE3903581A1 (en) * | 1989-02-07 | 1990-08-16 | Boehringer Mannheim Gmbh | FABRIC PLASMINOGEN ACTIVATOR DERIVATIVE |
-
1989
- 1989-07-14 DE DE3923339A patent/DE3923339A1/en not_active Withdrawn
-
1990
- 1990-05-22 IE IE184890A patent/IE66006B1/en not_active IP Right Cessation
- 1990-05-24 NZ NZ233796A patent/NZ233796A/en unknown
- 1990-05-28 DE DE59008693T patent/DE59008693D1/en not_active Expired - Fee Related
- 1990-05-28 IL IL9453990A patent/IL94539A/en not_active IP Right Cessation
- 1990-05-28 ES ES90110096T patent/ES2070210T3/en not_active Expired - Lifetime
- 1990-05-28 AT AT90110096T patent/ATE119940T1/en not_active IP Right Cessation
- 1990-05-28 CA CA002017636A patent/CA2017636C/en not_active Expired - Fee Related
- 1990-05-28 EP EP90110096A patent/EP0400545B1/en not_active Expired - Lifetime
- 1990-05-28 AU AU56009/90A patent/AU623781B2/en not_active Ceased
- 1990-05-29 ZA ZA904089A patent/ZA904089B/en unknown
- 1990-05-29 JP JP2139539A patent/JPH0327286A/en active Pending
- 1990-05-30 FI FI902700A patent/FI101475B/en not_active IP Right Cessation
- 1990-05-30 CZ CS902676A patent/CZ282035B6/en not_active IP Right Cessation
- 1990-05-30 HU HU903267A patent/HU216870B/en not_active IP Right Cessation
- 1990-05-30 NO NO90902405A patent/NO902405L/en unknown
- 1990-05-30 DD DD341150A patent/DD300109A5/en unknown
- 1990-05-31 PT PT94227A patent/PT94227B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
IE66006B1 (en) | 1995-11-29 |
JPH0327286A (en) | 1991-02-05 |
CZ267690A3 (en) | 1997-04-16 |
PT94227B (en) | 1997-01-31 |
DE3923339A1 (en) | 1990-12-06 |
FI902700A0 (en) | 1990-05-30 |
CZ282035B6 (en) | 1997-04-16 |
HU216870B (en) | 1999-09-28 |
HU903267D0 (en) | 1990-10-28 |
AU623781B2 (en) | 1992-05-21 |
FI101475B1 (en) | 1998-06-30 |
AU5600990A (en) | 1990-12-06 |
IL94539A0 (en) | 1991-03-10 |
HUT54734A (en) | 1991-03-28 |
IL94539A (en) | 1996-08-04 |
IE901848L (en) | 1990-11-30 |
ZA904089B (en) | 1991-03-27 |
ES2070210T3 (en) | 1995-06-01 |
NO902405D0 (en) | 1990-05-30 |
ATE119940T1 (en) | 1995-04-15 |
CA2017636C (en) | 2000-05-02 |
DD300109A5 (en) | 1992-05-21 |
DE59008693D1 (en) | 1995-04-20 |
NO902405L (en) | 1990-12-03 |
EP0400545B1 (en) | 1995-03-15 |
EP0400545A1 (en) | 1990-12-05 |
PT94227A (en) | 1991-02-08 |
NZ233796A (en) | 1992-07-28 |
FI101475B (en) | 1998-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6520086A (en) | Human mutant tPA with modified glycosylation sites | |
AU7008887A (en) | Novel human tissue-type plasminogen activator polypeptides | |
AU4816790A (en) | Method of modifying cellular differentiation and function and compositions therefor | |
SG139553A1 (en) | 7-substituted-hept-6-enoic and -heptanoic acids and derivatives thereof | |
AU7130891A (en) | Vectors and compounds for expression of zymogen forms of human protein c | |
AU633307B2 (en) | Dissolution of gas | |
EP0328957A3 (en) | Mixture of a thrombolytically acting and an antithrombolytically acting substance | |
AU7090687A (en) | Modified tissue-type plasminogen activators | |
AU625234B2 (en) | Stabilization of glycosylized t-pa | |
AU2732988A (en) | Vectors and compounds for expression of zymogen forms of human protein c | |
AU623781B2 (en) | Derivative of tissue-type plasminogen activator | |
AU4090589A (en) | The use of plasminogen activator inhibitor (pai-2) for immunosuppression | |
AU2218492A (en) | Proteolytic perhydorlysis system and method of use for bleaching | |
AU6651794A (en) | Automatisation of electro-oculographic examination | |
AU7090587A (en) | Modified plasminogen activators | |
AU2804989A (en) | Novel human tissue-type plasminogen activator variant | |
AU609337B2 (en) | Tissue plasminogen activator (t-pa) muteins and processes for the preparation thereof | |
AU4862790A (en) | New tissue plasminogen activator | |
AU7696087A (en) | Recombinant human tissue plasminogen activator composition | |
AU7554687A (en) | Modified tissue plasminogen activator | |
AU4743593A (en) | Mammalian GAP-43 compositions and methods of use | |
CS180888A1 (en) | Connection of pulse-regulated source's control unit | |
AU619697C (en) | Thrombolytic composition containing tissue type plasminogen activator or derivative thereof | |
IE871856L (en) | "modified tissue plasminogen activator" | |
IE883342L (en) | Human tissue-type plasminogen activator variant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |